β€’
Jun 30, 2023

Healthpeak Q2 2023 Earnings Report

Announced second quarter 2023 results.

Key Takeaways

Healthpeak Properties reported second quarter results, including net income of $0.09 per share, Nareit FFO of $0.45 per share, and FFO as Adjusted of $0.45 per share. The company updated its full year 2023 diluted earnings guidance to a range of $0.49 – $0.53 per share and increased the midpoint of 2023 FFO as Adjusted guidance by $0.01 per share.

Net income of $0.09 per share.

Nareit FFO of $0.45 per share.

FFO as Adjusted of $0.45 per share.

Blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 4.8%.

Total Revenue
$135M
Previous year: $132M
+2.2%
EPS
$0.25
Previous year: $0.27
-7.4%
Net Debt to Adjusted EBITDAre
5.1
Gross Profit
$324M
Previous year: $303M
+6.8%
Cash and Equivalents
$104M
Previous year: $73M
+42.1%
Total Assets
$15.6B
Previous year: $15.3B
+1.9%

Healthpeak

Healthpeak

Forward Guidance

Healthpeak updated the following guidance ranges for full year 2023: Diluted earnings per common share from $0.52 – $0.58 to $0.49 – $0.53, Diluted Nareit FFO per share from $1.71 – $1.77 to $1.72 – $1.76, Diluted FFO as Adjusted per share from $1.71 – $1.77 to $1.73 – $1.77, Total Portfolio Same-Store Cash (Adjusted) NOI growth from 3.00% – 4.50% to 3.25% – 4.75%.